Answers are grounded in this paper and cite their sources.
To evaluate the co-prescription of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) and gepants (small molecule CGRP receptor antagonists) at a tertiary headache center.
No takes yet. Share an insight, caveat, or question.
Nandyala et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: